checkAd

     165  0 Kommentare Gilead Named Number One Overall Philanthropic Funder of HIV-Related Programs for Second Year in a Row by Funders Concerned About AIDS

    Gilead Sciences, Inc. (Nasdaq: GILD) today was recognized as the number one philanthropic funder of HIV-related programs for the second year in a row, in a new report released by Funders Concerned About AIDS (FCAA). FCAA’s annual Philanthropic Support to Address HIV and AIDS report is widely regarded as the most comprehensive study of its kind, and analyzed data from more than 5,000 grants, disbursed by 187 funders and awarded to 2,800 grantee organizations. The 2023 report analyzed 2021 funding data – the most recent yearly data available – and found that Gilead distributed more than 1,000 HIV-related grants totaling almost $240 million in HIV-related projects, ranking the company once again as the number one overall funder of HIV-related programs both globally and in the U.S.

    “Gilead’s philanthropic contributions are driven by our distinct and enduring commitment to health equity,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences. “We know that progress against HIV depends on more than scientific innovation, which is why we support the community organizations doing remarkable work to eliminate barriers to care. This level of collaboration is essential in the work to help end the HIV epidemic for everyone, everywhere.”

    In addition to being recognized as the number one philanthropic funder of HIV-related programs both overall (globally) and in the U.S., Gilead was also recognized as the number one funder of organizations across a range of categories, including:

    • Number one funder of programs and services for BIPOC communities in the United States
    • Number one funder of programs providing support for gay men and other men who have sex with men
    • Number one funder of programs providing support for sex workers
    • Number one funder of programs supporting Transgender communities
    • Number one funder of programs providing support for people who use drugs
    • Number one funder of capacity building/leadership development programs
    • Number one HIV-related funder addressing the COVID-19 pandemic

    Additional recognitions include:

    • Number two funder of children and youth programs
    • Number two funder of women and girls programs
    • Number two funder of PrEP awareness and educational programs

    “We’re grateful for the institutions that have stepped up to provide funding for the communities most impacted by HIV and AIDS,” said Masen Davis, Executive Director, Funders Concerned About AIDS. “This support is more essential than ever given the incredibly challenging environment in which we find ourselves. Private philanthropy is absolutely critical to achieving the global targets for HIV and AIDS.”

    Seite 1 von 2



    Diskutieren Sie über die enthaltenen Werte



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Gilead Named Number One Overall Philanthropic Funder of HIV-Related Programs for Second Year in a Row by Funders Concerned About AIDS Gilead Sciences, Inc. (Nasdaq: GILD) today was recognized as the number one philanthropic funder of HIV-related programs for the second year in a row, in a new report released by Funders Concerned About AIDS (FCAA). FCAA’s annual Philanthropic …

    Schreibe Deinen Kommentar

    Disclaimer